Page 43 - Read Online

Page 14 of 18 Laustsen-Kiel et al. Plast Aesthet Res 2024;11:17 https://dx.doi.org/10.20517/2347-9264.2024.32

diagnosis, severity and available treatments. J Pers Med 2021;11:402. DOI PubMed PMC
63. de Sire A, Losco L, Cigna E, et al. Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer
related lymphedema rehabilitation: a proof-of-principle study. Eur Rev Med Pharmacol Sci 2020;24:4476-85. DOI PubMed
64. Aldrich MB, Rasmussen JC, Fife CE, Shaitelman SF, Sevick-Muraca EM. The development and treatment of lymphatic dysfunction
in cancer patients and survivors. Cancers 2020;12:2280. DOI PubMed PMC
65. Seward C, Skolny M, Brunelle C, Asdourian M, Salama L, Taghian AG. A comprehensive review of bioimpedance spectroscopy as a
diagnostic tool for the detection and measurement of breast cancer-related lymphedema. J Surg Oncol 2016;114:537-42. DOI
PubMed
66. Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective
cohort analysis. J Plast Reconstr Aesthet Surg 2018;71:1041-50. DOI PubMed
67. Koehler LA, Mayrovitz HN. Spatial and temporal variability of upper extremity edema measures after breast cancer surgery. Lymphat
Res Biol 2019;17:308-15. DOI PubMed PMC
68. Mayrovitz HN. Medical applications of skin tissue dielectric constant measurements. Cureus 2023;15:e50531. DOI PubMed PMC
69. Mayrovitz HN, Arzanova E, Somarriba S, Eisa S. Factors affecting interpretation of tissue dielectric constant (TDC) in assessing
breast cancer treatment related lymphedema (BCRL). Lymphology 2019;52:92-102. PubMed
70. Polat AK, Karabacak U, Mutlu V, Tomak L, Bilgici A. Early diagnosis of lymphedema after breast cancer treatment: bio-impedance
spectroscopy. J Breast Health 2017;13:83-7. DOI PubMed PMC
71. Watanabe S, Kajita H, Suzuki Y, et al. Photoacoustic lymphangiography is a possible alternative for lymphedema staging. J Vasc
Surg Venous Lymphat Disord 2022;10:1318-24.e2. DOI
72. Zackrisson S, van de Ven SMWY, Gambhir SS. Light in and sound out: emerging translational strategies for photoacoustic imaging.
Cancer Res 2014;74:979-1004. DOI PubMed PMC
73. O'Toole J, Jammallo LS, Miller CL, Skolny MN, Specht MC, Taghian AG. Screening for breast cancer-related lymphedema: the need
for standardization. Oncologist 2013;18:350-2. DOI PubMed PMC
74. Figueroa BA, Lammers JD, Al-malak M, Pandey S, Chen WF. Lymphoscintigraphy versus indocyanine green lymphography-which
should be the gold standard for lymphedema imaging? Lymphatics 2023;1:25-33. DOI
75. Sun F, Skolny MN, Swaroop MN, et al. The need for preoperative baseline arm measurement to accurately quantify breast cancer-
related lymphedema. Breast Cancer Res Treat 2016;157:229-40. DOI
76. Executive Committee. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society
of lymphology. Lymphology 2016;49:170-84. PubMed
77. Executive Committee of the International Society of Lymphology.. The diagnosis and treatment of peripheral lymphedema: 2020
consensus document of the international society of lymphology. Lymphology 2020;53:3-19. PubMed
78. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the
international society of lymphology. Lymphology 2013;46:1-11. PubMed
79. Halsted WS. The results of operations for the cure of cancer of the breast performed at the johns Hopkins hospital from June, 1889, to
January, 1894. Ann Surg 1894;20:497-555. DOI PubMed PMC
80. Christiansen P, Mele M, Bodilsen A, Rocco N, Zachariae R. Breast-conserving surgery or mastectomy? Impact on survival. Ann Surg
Open 2022;3:e205. DOI PubMed PMC
81. Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA. Axillary lymph node dissection for breast cancer: efficacy and
complication in developing countries. J Glob Oncol 2018;4:1-8. DOI PubMed PMC
82. Tfayli A, Temraz S, Abou Mrad R, Shamseddine A. Breast cancer in low- and middle-income countries: an emerging and challenging
epidemic. J Oncol 2010;2010:490631. DOI PubMed PMC
83. Boyages J, Vicini FA, Manavi BA, et al. Axillary treatment and chronic breast cancer-related lymphedema: implications for
prospective surveillance and intervention from a randomized controlled trial. JCO Oncol Pract 2023;19:1116-24. DOI PubMed
PMC
84. Basta MN, Wu LC, Kanchwala SK, et al. Reliable prediction of postmastectomy lymphedema: the risk assessment tool evaluating
lymphedema. Am J Surg 2017;213:1125-33.e1. DOI
85. Coriddi M, Khansa I, Stephens J, Miller M, Boehmler J, Tiwari P. Analysis of factors contributing to severity of breast cancer-related
lymphedema. Ann Plast Surg 2015;74:22-5. DOI PubMed PMC
86. Lee J, Jung JH, Kim WW, et al. Ten-year oncologic outcomes in T1-3N1 breast cancer after targeted axillary sampling: a
retrospective study. Ann Surg Oncol 2023;30:4669-77. DOI PubMed
87. Miller CL, Specht MC, Skolny MN, et al. Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011
protocol to mastectomy patients. Breast Cancer Res Treat 2014;144:71-7. DOI PubMed PMC
88. Afif M, Kouhen F, Benjaafar N. Hypofractionated radiation therapy in the management of breast cancer: analysis of 350 patients
treated in the national institute of oncology of Rabat, Morocco. Tumori 2019;105:4-5.
89. Bellefqih S, Elmajjaoui S, Aarab J, et al. Hypofractionated regional nodal irradiation for women with node-positive breast cancer. Int
J Radiat Oncol Biol Phys 2017;97:563-70. DOI
90. Chaffai I, Cao K, Kissel M, et al. [Patient selection and early tolerance of whole breast irradiation according to the "fast forward"
protocol: preliminary results]. Cancer Radiother 2022;26:542-6. DOI PubMed
91. Coen JJ, Taghian AG, Kachnic LA, Assaad SI, Powell SN. Risk of lymphedema after regional nodal irradiation with breast